NextCure, Inc. (NXTC)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
Key ratios (FY2025)
-159.8%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | $22.38M | $6.35M | — | — |
| Operating Income | -$57.62M | -$59.75M | -$67.64M | -$75.91M | -$70.77M | -$41.23M | -$37.48M | -$23.20M | — |
| Net Income | -$55.84M | -$55.65M | -$62.72M | -$74.73M | -$69.39M | -$36.60M | -$33.74M | -$22.80M | — |
| EPS (Diluted) | $-19.65 | $-23.88 | $-2.25 | $-2.69 | $-2.51 | $-1.33 | — | — | — |
| Total Assets | $50.18M | $80.86M | $128.04M | $184.16M | $242.39M | $306.64M | $356.17M | $147.63M | — |
| Total Liabilities | $15.24M | $15.39M | $13.62M | $16.63M | $9.00M | $12.92M | $34.68M | $32.35M | — |
| Shareholders' Equity | $34.94M | $65.47M | $114.42M | $167.53M | $233.39M | $293.72M | $321.48M | -$46.94M | -$24.41M |
| Cash & Equivalents | $25.98M | $27.73M | $13.08M | $26.63M | $12.34M | $32.77M | $34.09M | $135.17M | — |
| Operating Cash Flow | -$49.61M | -$40.80M | -$52.97M | -$53.89M | -$57.28M | -$44.95M | -$35.62M | $7.99M | — |
| Capital Expenditures | — | $474.0K | $820.0K | $2.12M | $2.36M | $7.13M | $3.37M | $3.06M | — |
| Shares Outstanding | 3.51M | 2.33M | 27.90M | 27.77M | 27.68M | 27.57M | 27.50M | 1.37M | — |
| Dividends Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — |